scholarly journals Balloon valvuloplasty in pulmonary valve atresia and critical pulmonary stenosis

1990 ◽  
Vol 15 (2) ◽  
pp. A241 ◽  
Author(s):  
Larry Latson ◽  
John Choatham ◽  
John Kugler ◽  
David Danford ◽  
Carl Gumbiner ◽  
...  
2021 ◽  
Vol 6 (2) ◽  
pp. 67-74
Author(s):  
Dyahris Koentartiwi

Abstract Critical pulmonary stenosis (PS) is used in infants born with very severe narrowing valves and requires treatment soon after birth. At four months old, an A-12-month-old boy was diagnosed with critical pulmonary stenosis but still successfully managed by percutaneous transluminal balloon valvuloplasty (PTBV) with satisfactory results without serious complications. Since he was born, cyanosis was seen at his lips and fingertip, with oxygen saturation around 60% until 70%. Echocardiography showed critical pulmonary stenosis, atrial septal defect (ASD), and patent ductus arteriosus (PDA). Percutaneous transluminal balloon valvuloplasty (PTBV) is accepted as the treatment of choice for critical pulmonary valve stenosis in many centers worldwide with significant results. After PTBV, he experienced improvement condition as no cyanosis was observed and oxygen saturation was 96%. This case was our first PTBV intervention case in our hospital and gave satisfactory results, although the intervention was delayed due to our limited resources before. Keywords: cyanosis, critical pulmonary stenosis, percutaneous transluminal balloon valvuloplasty


2014 ◽  
Vol 142 (9-10) ◽  
pp. 542-546
Author(s):  
Vojislav Parezanovic ◽  
Milan Djukic ◽  
Sanja Dzelebdzic ◽  
Tamara Ilisic ◽  
Igor Stefanovic ◽  
...  

Introduction. Pulmonary artery stenosis (PS) is a congenital heart defect which occurs in 10% of all congenital heart defects. Pulmonary balloon valvuloplasty (BVP) has been the treatment of choice of PS over the last 30 years. Objective. The purpose of this study was to evaluate the efficacy of this method based on middle-term hospital follow-up, and safety of BVP based on our experience. Methods. The study included 88 patients diagnosed with PS. The patients were divided into three groups based on the severity of the disease. Also, they were divided into two age groups in order to analyze the frequency of complications. Hemodynamic measurements and echocardiography results were recorded before, 24-36 hours after BVP and at the end of follow-up. Results. The studied group involved patients of average age 3.75?4.3 years (20 days to 17 years). Immediately after BVP a significant decrease of pressure gradient across the pulmonary valve (PV) was recorded in all patients; this result was similar in all 3 groups of patients regardless of the severity of stenosis (p<0.001). Complications of BVP occurred most commonly in children up to 12 months of age (ventricular tachycardia 4.5% and supraventricular tachycardia 6.8%). Pulmonary valve insufficiency after dilatation occurred in 6.6% of cases, and was most common in children aged up to 12 months. In 87 (98.9%) patients BVP was a definitive solution, and a significant residual stenosis was not recorded during follow-up. Conclusion. BVP is a safe and effective procedure in the treatment of isolated PS in children, regardless of the severity of stenosis but also regardless of patients? age.


1988 ◽  
Vol 10 (6) ◽  
pp. 179-182
Author(s):  
Jon B. Tingelstad

Percutaneous balloon valvuloplasty is an effective alternative to open-heart surgery for moderate and severe pulmonary valvular stenosis and is the treatment of choice for the typical form of this congenital heart defect in many medical centers. Standard right and left heart catheterizations with biplane cineangiocardiography to evaluate the anatomy and motion of the pulmonary valve are performed. If the criteria for balloon valvuloplasty are met, a balloon catheter is inserted in the vein and advanced so that the balloon straddles the stenotic pulmonary valve. The balloon is inflated by hand until the constriction caused by the stenosis disappears. The procedure is repeated to confirm the absence of the constriction and the catheter is removed. Balloon valvuloplasty is a safe procedure, and no fatalities or major morbidity have been reported.


2015 ◽  
Vol 36 (6) ◽  
pp. 1186-1193 ◽  
Author(s):  
Christina Ronai ◽  
Rahul H. Rathod ◽  
Audrey C. Marshall ◽  
Rebecca Oduor ◽  
Kimberlee Gauvreau ◽  
...  

Thorax ◽  
1992 ◽  
Vol 47 (3) ◽  
pp. 179-183 ◽  
Author(s):  
A Smolinsky ◽  
R Arav ◽  
J Hegesh ◽  
A Lusky ◽  
D A Goor

2017 ◽  
Vol 27 (6) ◽  
pp. 1232-1234
Author(s):  
Kalyani R. Trivedi ◽  
Laurence Robinson ◽  
Alain Fraisse

AbstractSome patients with pulmonary valve stenosis do not respond to balloon valvuloplasty and must undergo surgical repair. We report the case of a 12-year-old child with pulmonary valve stenosis and Noonan syndrome in whom we performed transcatheter Melody pulmonary valve implantation after balloon dilation failed. The result was excellent. This technique can be proposed as an alternative to surgery in such cases.


1993 ◽  
Vol 22 (7) ◽  
pp. 1944-1947 ◽  
Author(s):  
Janusz B. Burzynski ◽  
Daniel A. Kveselis ◽  
Craig J. Byrum ◽  
Rae-Ellen W. Kavey ◽  
Frank C. Smith ◽  
...  

2019 ◽  
Vol 29 (4) ◽  
pp. 492-498 ◽  
Author(s):  
Raymond N. Haddad ◽  
Najib Hanna ◽  
Ramy Charbel ◽  
Linda Daou ◽  
Ghassan Chehab ◽  
...  

AbstractObjective:To assess the feasibility, safety, and efficiency of ductal stenting in pulmonary atresia with intact ventricular septum or critical pulmonary stenosis after balloon pulmonary valvuloplasty.Background:Ductal stenting in pulmonary atresia with intact ventricular septum is a re-emerging and promising technique. There is little data available on its outcomes after establishing prograde pulmonary blood flow.Methods:We retrospectively reviewed all neonates with pulmonary atresia with intact ventricular septum or critical pulmonary stenosis who underwent ductal stenting after balloon valvuloplasty. Ductal stenting was performed either in the same setting (group A) or a few days later after balloon valvuloplasty (group B). We compared the two groups.Results:Eighteen coronary stents were transvenously delivered and successfully deployed in 18 newborns. There was no procedure-related mortality. The median hospital stay post-intervention was 6 days with a mean discharge oxygen saturation of 94%. Group A had a shorter overall hospital stay with a shorter overall time of irradiation but with a longer overall procedural time. On a follow-up of 18 months, no re-intervention for stent failure or overflow was undertaken. The median stent patency based on echocardiography was 12 months.Conclusion:Stenting the arterial duct in pulmonary atresia with intact ventricular septum or critical pulmonary stenosis is a feasible, safe, and efficient technique. It avoids surgery or long hospital stay with prostaglandin infusion. The minimal 6 months stent longevity provides a period of time long enough to decide whether the right ventricular diastolic function is normalised or Glenn surgery is still needed.


2016 ◽  
Vol 8 (5) ◽  
pp. 643-645 ◽  
Author(s):  
Carles Bautista-Rodriguez ◽  
Javier Rodriguez-Fanjul ◽  
Julio Moreno Hernando ◽  
Javier Mayol ◽  
Jose Maria Caffarena-Calvar

We report two cases of newborns with critical pulmonary stenosis having intact ventricular septum, who underwent pulmonary valve balloon valvuloplasty followed by banding of a patent ductus arteriosus. Transcatheter pulmonary valvuloplasty was performed one week after delivery. Following the procedure, both developed “circular shunting” as a consequence of left-to-right ductal flow and pulmonary regurgitation. This in turn caused increased blood flow into a dysfunctional right ventricle and low systemic cardiac output syndrome. The PDA banding was performed urgently as a rescue measure in order to restore systemic flow while still maintaining some duct-dependent pulmonary blood flow. This approach resolved the circular shunting. Outcome was favorable in both the patients.


Sign in / Sign up

Export Citation Format

Share Document